Search results
UC San Diego study finds plant virus may slow the progression of cancer
KSWB articles via Yahoo News· 2 days agoTo make the nanoparticles, researchers grew black-eyed pea plants and infected them with the virus....
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise
MedPage Today· 7 days agoNews, features, and commentary about cancer-related issues
Mass. community organizes parade for 8-year-old cancer patient
WCVB Boston· 2 days agoAdelia, who is known as "Adelia the Wonder Girl" on social media, was diagnosed with diffuse midline...
Fundamental Research Paved the Way for the Development of Vorasidenib
National Cancer Institute· 5 days agoDuring the 2023 American Society of Clinical Oncology (ASCO) annual meeting, a plenary presentation...
Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2...
Nature· 1 day agoImmunosuppressive tumor microenvironment (TME) contributes to tumor progression and causes major obstacles for cancer therapy. Phosphoglycerate mutase 1 (PGAM1) is a key enzyme ...
New Sylvester Brain Tumor Institute offering personalized treatment
CBS News· 19 hours agoThere's a new way to treat patients with brain cancer at UM's Sylvester Comprehensive Cancer Center.
Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress By Investing.com
Investing.com· 4 hours agoThe company highlighted the closing of a private placement financing, raising $19.25 million, and...
UF Health scientists make breakthrough in possible cancer treatment
The Gainesville Sun via Yahoo News· 2 days agoUF was given permission by the owners of the dogs, which had developed terminal brain cancer with no other treatment options, to conduct the trial in collaboration with UF's ...
Lisata Therapeutics gets 2024 off to a strong start as it prepares for crucial ASCEND trial results
Proactive Investors· 6 days agoMazzo highlighted Lisata's effective cash management, with over $43 million in funds ensuring...
Candel Lights Up Investors' Portfolio With 830% Gain
RTT News· 15 hours agoShares of Candel Therapeutics Inc. (CADL) have gained more than 830% in the past 2 months, thanks to the substantial progress achieved across its clinical programs.